Following encouraging trial findings , retatrutide, a novel peptide therapy for treating adult-onset metabolic disorder, has secured regulatory approval from the Healthcare and Products Agency ( MHRA https://adrianaauzs665469.blogproducer.com/49034628/retatrutide-medication-peptide-british-green-light-and-availability